Revumenib as A New Therapeutic Intervention for Relapsed or Refractory KMT2A-Rearranged Acute Lymphoblastic Leukemia

KMT2A (MLL)-rearranged acute lymphoblastic leukemia (ALL) is one of the most severe forms of leukemia that corresponds with high mortality, especially in relapsed or refractory cases. ALL affects both adults and children, thereby necessitating the need for treatment options that provide higher effi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Khushbakht Baloch, Muniba Shoaib, Mishal Fatima
Formato:	Artigo
Idioma:	Inglês
Publicado em:	ziauddin University 2025-04-01
coleção:	Pakistan Journal of Medicine and Dentistry
Assuntos:	Acute leukemia Acute leukemia treatment Revumenib Abbreviations: 1 Acute Lymphoblastic Leukemia (ALL)
Acesso em linha:	https://ojs.zu.edu.pk/pjmd/article/view/3582
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!